European Society of Cardiology

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

R&D

Increasingly, electrophysiologists are exploring approaches that activate the heart through its intrinsic conduction pathways.

News

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines.

News

A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.